Cambridge Investment Research Advisors
ARCC icon

Cambridge Investment Research Advisors’s Ares Capital ARCC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ARCC Stock Details ARCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
1,081,390
+81,975
+8% +$1.53M 0.04% 414
2026
Q1 		$18M Sell
999,415
-52,073
-5% -$1.01M 0.05% 405
2025
Q4 		$21.3M Sell
1,051,488
-19,411
-2% -$392K 0.06% 345
2025
Q3 		$21.9M Sell
1,070,899
-61,581
-5% -$1.37M 0.06% 314
2025
Q2 		$24.9M Buy
1,132,480
+56,472
+5% +$1.2M 0.08% 263
2025
Q1 		$23.8M Buy
1,076,008
+67,597
+7% +$1.53M 0.08% 255
2024
Q4 		$22.1M Buy
1,008,411
+42,440
+4% +$916K 0.07% 257
2024
Q3 		$20.2M Buy
965,971
+95,325
+11% +$1.98M 0.07% 282
2024
Q2 		$18.1M Buy
870,646
+15,996
+2% +$334K 0.07% 280
2024
Q1 		$17.8M Buy
854,650
+25,871
+3% +$524K 0.07% 282
2023
Q4 		$16.6M Buy
828,779
+36,636
+5% +$715K 0.07% 272
2023
Q3 		$15.4M Buy
792,143
+18,695
+2% +$362K 0.07% 264
2023
Q2 		$14.5M Buy
773,448
+17,036
+2% +$315K 0.07% 283
2023
Q1 		$13.8M Buy
756,412
+36,260
+5% +$685K 0.07% 287
2022
Q4 		$13.3M Buy
720,152
+89,739
+14% +$1.69M 0.07% 287
2022
Q3 		$10.6M Buy
630,413
+44,582
+8% +$862K 0.06% 308
2022
Q2 		$10.5M Buy
585,831
+37,655
+7% +$742K 0.06% 322
2022
Q1 		$11.5M Buy
548,176
+30,622
+6% +$653K 0.05% 337
2021
Q4 		$11M Buy
517,554
+24,304
+5% +$505K 0.05% 352
2021
Q3 		$10M Buy
493,250
+37,854
+8% +$759K 0.05% 354
2021
Q2 		$8.92M Buy
455,396
+30,399
+7% +$589K 0.04% 403
2021
Q1 		$7.95M Buy
424,997
+56,005
+15% +$1.01M 0.04% 404
2020
Q4 		$6.23M Buy
368,992
+12,247
+3% +$190K 0.04% 442
2020
Q3 		$4.98M Buy
356,745
+2,491
+0.7% +$35.4K 0.03% 466
2020
Q2 		$5.12M Sell
354,254
-3,780
-1% -$51K 0.04% 432
2020
Q1 		$3.86M Buy
358,034
+43,780
+14% +$738K 0.04% 448
2019
Q4 		$5.86M Buy
314,254
+42,254
+16% +$784K 0.05% 404
2019
Q3 		$5.07M Buy
272,000
+46,069
+20% +$854K 0.04% 397
2019
Q2 		$4.05M Sell
225,931
-14,622
-6% -$259K 0.04% 475
2019
Q1 		$4.12M Buy
240,553
+23,209
+11% +$389K 0.04% 435
2018
Q4 		$3.39M Buy
217,344
+36,144
+20% +$598K 0.04% 450
2018
Q3 		$3.12M Buy
181,200
+19,644
+12% +$337K 0.03% 513
2018
Q2 		$2.66M Buy
161,556
+27,694
+21% +$455K 0.03% 550
2018
Q1 		$2.12M Buy
133,862
+4,043
+3% +$64.1K 0.02% 608
2017
Q4 		$2.04M Sell
129,819
-2,301
-2% -$37.4K 0.02% 584
2017
Q3 		$2.17M Sell
132,120
-375
-0.3% -$6.07K 0.03% 510
2017
Q2 		$2.17M Sell
132,495
-6,427
-5% -$108K 0.03% 485
2017
Q1 		$2.41M Buy
138,922
+9,933
+8% +$172K 0.04% 400
2016
Q4 		$2.13M Buy
128,989
+3,940
+3% +$62K 0.04% 414
2016
Q3 		$1.94M Sell
125,049
-36,774
-23% -$564K 0.04% 440
2016
Q2 		$2.3M Buy
161,823
+41,704
+35% +$619K 0.05% 347
2016
Q1 		$1.78M Sell
120,119
-4,348
-3% -$59.9K 0.04% 382
2015
Q4 		$1.77M Sell
124,467
-4,706
-4% -$71.4K 0.04% 378
2015
Q3 		$1.87M Buy
129,173
+6,686
+5% +$105K 0.05% 322
2015
Q2 		$2.02M Buy
122,487
+4,197
+4% +$70.1K 0.06% 310
2015
Q1 		$2.03M Buy
118,290
+3,134
+3% +$52.3K 0.06% 312
2014
Q4 		$1.8M Buy
115,156
+5,515
+5% +$88K 0.06% 316
2014
Q3 		$1.77M Buy
109,641
+5,593
+5% +$94.5K 0.05% 351
2014
Q2 		$1.86M Buy
104,048
+7,268
+8% +$125K 0.06% 288
2014
Q1 		$1.71M Buy
96,780
+35,471
+58% +$633K 0.06% 296
2013
Q4 		$1.09M Buy
61,309
+16,783
+38% +$296K 0.04% 370
2013
Q3 		$770K Buy
44,526
+20,882
+88% +$366K 0.03% 452
2013
Q2 		$407K Buy
+23,644
New +$412K 0.02% 630

Other funds holding ARCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GAM
Generali Asset Management Trieste, Italy $5.53B AUM 35.1% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cambridge Investment Research Advisors's ARCC Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Ares Capital (ARCC) stake by 8.2% in Q2 2026, buying an estimated $1.53M and bringing the position to 1,081,390 shares worth $20M. The position accounts for 0.04% of the portfolio, ranked #414.

Cambridge Investment Research Advisors first reported a position in ARCC in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.9M in Q2 2025. 787 funds tracked by Wall St. Rank hold ARCC as of Q2 2026.

  • Cambridge Investment Research Advisors held 1,081,390 shares of Ares Capital worth $20M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 81,975 Ares Capital shares in Q2 2026, an estimated $1.53M.
  • Ares Capital made up 0.04% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #414 holding.
  • Cambridge Investment Research Advisors first reported a position in Ares Capital in Q2 2013 and has held it in 53 quarters since.
  • Cambridge Investment Research Advisors's Ares Capital position peaked at $24.9M in Q2 2025.
  • 787 funds tracked by Wall St. Rank held Ares Capital as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.